Literature DB >> 20015515

Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides.

K Yaragudri Vinod1, Suham A Kassir, Basalingappa L Hungund, Thomas B Cooper, J John Mann, Victoria Arango.   

Abstract

Recent studies in rodents have suggested a role for the central endocannabinoid system in the regulation of mood and alcohol related behaviors. Alcohol use disorder is often associated with suicidal behavior. In the present study, we examined whether abnormalities in the endocannabinoid system in the ventral striatum are associated with alcohol dependence and suicide. The levels of CB1 receptors, receptor-mediated G-protein signaling, and activity and level of the fatty acid amide hydrolase (FAAH) were analyzed postmortem in the ventral striatum of alcohol-dependent nonsuicides (CA, n=9), alcohol-dependent suicides (AS, n=9) and nonpsychiatric controls (C, n=9). All subjects underwent a psychological autopsy, and toxicological and neuropathological examinations. The levels of the CB1 receptors and the CB1 receptor-mediated G-protein signaling were significantly lower in the ventral striatum of CA compared to the control group. However, these parameters were elevated in AS when compared to CA group. The activity of FAAH enzyme was lower in CA compared to the control group while it was found to be significantly higher in AS compared with CA group. These findings suggest that alcohol dependence is associated with the downregulation of the CB1 receptors, while suicide is linked to the upregulation of these receptors in the ventral striatum. Alteration in the activity of FAAH enzyme that regulates the anandamide (AEA) content might in turn explain differences in the CB1 receptor function in alcohol dependence and suicide. These findings may have etiological and therapeutic implications for the treatment of alcohol addiction and suicidal behavior. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015515      PMCID: PMC2878847          DOI: 10.1016/j.jpsychires.2009.11.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  68 in total

1.  Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey.

Authors:  R C Kessler; G Borges; E E Walters
Journal:  Arch Gen Psychiatry       Date:  1999-07

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Relapse to drug-seeking: neural and molecular mechanisms.

Authors:  D W Self; E J Nestler
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

Review 4.  The functional neuroanatomy of brain cannabinoid receptors.

Authors:  C S Breivogel; S R Childers
Journal:  Neurobiol Dis       Date:  1998-12       Impact factor: 5.996

5.  Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe.

Authors:  Lescia K Tremblay; Claudio A Naranjo; Simon J Graham; Nathan Herrmann; Helen S Mayberg; Stephanie Hevenor; Usoa E Busto
Journal:  Arch Gen Psychiatry       Date:  2005-11

6.  Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims.

Authors:  K Yaragudri Vinod; Victoria Arango; Shan Xie; Suham A Kassir; J John Mann; Thomas B Cooper; Basalingappa L Hungund
Journal:  Biol Psychiatry       Date:  2005-03-01       Impact factor: 13.382

7.  Suicide methods and presence of intoxicating abusable substances: some clinical and public health implications.

Authors:  C L Rich; D M Dhossche; S Ghani; G Isacsson
Journal:  Ann Clin Psychiatry       Date:  1998-12       Impact factor: 1.567

8.  Toward a clinical model of suicidal behavior in psychiatric patients.

Authors:  J J Mann; C Waternaux; G L Haas; K M Malone
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

9.  Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.

Authors:  Sachin Patel; Craig T Roelke; David J Rademacher; William E Cullinan; Cecilia J Hillard
Journal:  Endocrinology       Date:  2004-08-26       Impact factor: 4.736

10.  Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane.

Authors:  B S Basavarajappa; T B Cooper; B L Hungund
Journal:  Brain Res       Date:  1998-05-18       Impact factor: 3.252

View more
  43 in total

1.  Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.

Authors:  J Hirvonen; P Zanotti-Fregonara; J C Umhau; D T George; D Rallis-Frutos; C H Lyoo; C-T Li; C S Hines; H Sun; G E Terry; C Morse; S S Zoghbi; V W Pike; R B Innis; M Heilig
Journal:  Mol Psychiatry       Date:  2012-07-10       Impact factor: 15.992

Review 2.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

Review 3.  Physiological processes underlying organ injury in alcohol abuse.

Authors:  Flavia M Souza-Smith; Charles H Lang; Laura E Nagy; Shannon M Bailey; Loren H Parsons; Gary J Murray
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

4.  Selective breeding for high alcohol preference is associated with increased sensitivity to cannabinoid reward within the nucleus accumbens shell.

Authors:  Sheketha R Hauser; Simon N Katner; Robert A Waeiss; William A Truitt; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Pharmacol Biochem Behav       Date:  2020-07-23       Impact factor: 3.533

Review 5.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

6.  Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling.

Authors:  Andrea Balla; Bin Dong; Borehalli M Shilpa; Kiran Vemuri; Alexandros Makriyannis; Subhash C Pandey; Henry Sershen; Raymond F Suckow; K Yaragudri Vinod
Journal:  Neuropharmacology       Date:  2017-11-03       Impact factor: 5.250

7.  Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala.

Authors:  Florence P Varodayan; Neeraj Soni; Michal Bajo; George Luu; Samuel G Madamba; Paul Schweitzer; Loren H Parsons; Marisa Roberto
Journal:  Addict Biol       Date:  2015-05-05       Impact factor: 4.280

8.  Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review.

Authors:  Laura Colino; Javier Herranz-Herrer; Elena Gil-Benito; Teresa Ponte-Lopez; Pablo Del Sol-Calderon; Maria Rodrigo-Yanguas; María Gil-Ligero; Antonio J Sánchez-López; Jose de Leon; Hilario Blasco-Fontecilla
Journal:  Curr Psychiatry Rep       Date:  2018-03-15       Impact factor: 5.285

Review 9.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 10.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.